- Empagliflozin Dosage and Albuminuria Reduction in CKD
10:00 AM - 12:00 PM
Empagliflozin Dosage and Albuminuria Reduction in CKD
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Effects of Empagliflozin on Health Care Use and Quality of Life in CKD in the United Kingdom: Results from EMPA-KIDNEY
10:00 AM - 12:00 PM
Effects of Empagliflozin on Health Care Use and Quality of Life in CKD in the United Kingdom: Results from EMPA-KIDNEY
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Validation of Impact Using SGLT2 Inhibitor in Changes of Body Weight and Serum Albumin for Elderly Patients with CKD: A Retrospective Observational Study
10:00 AM - 12:00 PM
Validation of Impact Using SGLT2 Inhibitor in Changes of Body Weight and Serum Albumin for Elderly Patients with CKD: A Retrospective Observational Study
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Increasing Use of SGLT2 Inhibitors in Patients with CKD and Heart Failure through Physician Education and Outreach Reduces Inpatient Admissions in a Value-Based Care Model
10:00 AM - 12:00 PM
Increasing Use of SGLT2 Inhibitors in Patients with CKD and Heart Failure through Physician Education and Outreach Reduces Inpatient Admissions in a Value-Based Care Model
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Targeted Clinician Emails to Promote SGLT2 Inhibitor Re-initiation after Discontinuation for Remediable Side Effects
10:00 AM - 12:00 PM
Targeted Clinician Emails to Promote SGLT2 Inhibitor Re-initiation after Discontinuation for Remediable Side Effects
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Effects of Empagliflozin on Serum Uric Acid and Gout in CKD
10:00 AM - 12:00 PM
Effects of Empagliflozin on Serum Uric Acid and Gout in CKD
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Patient-Level Factors Associated with the Prescription of SGLT2 Inhibitors in Patients with CKD
10:00 AM - 12:00 PM
Patient-Level Factors Associated with the Prescription of SGLT2 Inhibitors in Patients with CKD
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Benefits of Dapagliflozin in Slowing eGFR Decline in Patients with Different Rates of eGFR Loss
10:00 AM - 12:00 PM
Benefits of Dapagliflozin in Slowing eGFR Decline in Patients with Different Rates of eGFR Loss
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Implications of Acute GFR Change for the Effect of SGLT2 Inhibitors on Long-Term End Points
10:00 AM - 12:00 PM
Implications of Acute GFR Change for the Effect of SGLT2 Inhibitors on Long-Term End Points
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Real-Life Experience on the Effect of SGLT2 Inhibitors vs. Finerenone vs. Combination on Albuminuria in CKD
10:00 AM - 12:00 PM
Real-Life Experience on the Effect of SGLT2 Inhibitors vs. Finerenone vs. Combination on Albuminuria in CKD
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Effects of Zibotentan Alone and in Combination with Dapagliflozin on Fluid Retention in Patients with CKD
10:00 AM - 12:00 PM
Effects of Zibotentan Alone and in Combination with Dapagliflozin on Fluid Retention in Patients with CKD
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Cumulative Effects of Aldosterone Synthase and SGLT2 Inhibition on Albuminuria in People with CKD
10:00 AM - 12:00 PM
Cumulative Effects of Aldosterone Synthase and SGLT2 Inhibition on Albuminuria in People with CKD
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Insulin Glargine and SGLT2 Inhibitors Have Higher Risk of Major Adverse Cardiovascular Events (MACE) Compared with Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs) in a National Cohort of Veterans with Type 2 Diabetes (T2D) and CKD
10:00 AM - 12:00 PM
Insulin Glargine and SGLT2 Inhibitors Have Higher Risk of Major Adverse Cardiovascular Events (MACE) Compared with Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs) in a National Cohort of Veterans with Type 2 Diabetes (T2D) and CKD
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Insulin Glargine Compared with Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs) or SGLT2 Inhibitors Is Associated with Higher Risk of Alzheimer Disease and Alzheimer Disease-Related Dementias (AD/ADRD) in CKD
10:00 AM - 12:00 PM
Insulin Glargine Compared with Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs) or SGLT2 Inhibitors Is Associated with Higher Risk of Alzheimer Disease and Alzheimer Disease-Related Dementias (AD/ADRD) in CKD
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Comparative Effectiveness of Semaglutide, Liraglutide, and Dulaglutide for All-Cause Mortality in Type 2 Diabetes (T2D) with and without CKD: An Emulated Clinical Trial Observational Study
10:00 AM - 12:00 PM
Comparative Effectiveness of Semaglutide, Liraglutide, and Dulaglutide for All-Cause Mortality in Type 2 Diabetes (T2D) with and without CKD: An Emulated Clinical Trial Observational Study
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Risk of Gastroparesis Is Higher with Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs) but Risk of Death Is Higher with Insulin Glargine in Veterans with Type 2 Diabetes and CKD
10:00 AM - 12:00 PM
Risk of Gastroparesis Is Higher with Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs) but Risk of Death Is Higher with Insulin Glargine in Veterans with Type 2 Diabetes and CKD
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- SGLT2 Inhibitors, Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists, and the Risk of Hypokalemia and Hyperkalemia in a National Cohort of Veterans with Type 2 Diabetes
10:00 AM - 12:00 PM
SGLT2 Inhibitors, Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists, and the Risk of Hypokalemia and Hyperkalemia in a National Cohort of Veterans with Type 2 Diabetes
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Does CKD Modify the Effects of Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs) and SGLT2 Inhibitors on Weight Loss?
10:00 AM - 12:00 PM
Does CKD Modify the Effects of Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 RAs) and SGLT2 Inhibitors on Weight Loss?
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Effects of Glucagon-Like Peptide 1 Agonists (GLP-1 RAs) on Ectopic Fat Deposition in CKD: A Pilot and Feasibility Study (GLIMP)
10:00 AM - 12:00 PM
Effects of Glucagon-Like Peptide 1 Agonists (GLP-1 RAs) on Ectopic Fat Deposition in CKD: A Pilot and Feasibility Study (GLIMP)
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Trial Design and Baseline Characteristics from REMODEL: A Mechanistic Study of Semaglutide vs. Placebo in People with Type 2 Diabetes and CKD
10:00 AM - 12:00 PM
Trial Design and Baseline Characteristics from REMODEL: A Mechanistic Study of Semaglutide vs. Placebo in People with Type 2 Diabetes and CKD
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Effect of Spironolactone on Long-Term Outcomes in Patients with CKD
10:00 AM - 12:00 PM
Effect of Spironolactone on Long-Term Outcomes in Patients with CKD
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Effect of the RAS Inhibitors on Kidney Outcomes in Patients with Advanced CKD: A Systematic Review and Meta-Analysis
10:00 AM - 12:00 PM
Effect of the RAS Inhibitors on Kidney Outcomes in Patients with Advanced CKD: A Systematic Review and Meta-Analysis
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Impact of Renin-Angiotensin-Aldosterone-System Inhibition on Advanced CKD: A Retrospective Observational Study
10:00 AM - 12:00 PM
Impact of Renin-Angiotensin-Aldosterone-System Inhibition on Advanced CKD: A Retrospective Observational Study
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Mineralocorticoid Receptor Antagonist (MRA) Use Patterns following Potassium Binder Initiation: Insights from the DEMONSTRATE Database
10:00 AM - 12:00 PM
Mineralocorticoid Receptor Antagonist (MRA) Use Patterns following Potassium Binder Initiation: Insights from the DEMONSTRATE Database
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Effect of Ultrasound Renal Denervation in Patients with CKD: A Matched-Controlled Analysis of the RADIANCE Clinical Trial Program
10:00 AM - 12:00 PM
Effect of Ultrasound Renal Denervation in Patients with CKD: A Matched-Controlled Analysis of the RADIANCE Clinical Trial Program
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- The Acute Kidney Function Change with Fenofibrate Is Not Damaging: A Post Hoc Analysis of the FIELD Trial
10:00 AM - 12:00 PM
The Acute Kidney Function Change with Fenofibrate Is Not Damaging: A Post Hoc Analysis of the FIELD Trial
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Association of Fibrate Use with Greater Survival Independent of Baseline Kidney Function and Albuminuria
10:00 AM - 12:00 PM
Association of Fibrate Use with Greater Survival Independent of Baseline Kidney Function and Albuminuria
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Kidney Safety of Prescribed Oral Fibrates in Veterans without CKD
10:00 AM - 12:00 PM
Kidney Safety of Prescribed Oral Fibrates in Veterans without CKD
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Examining the Associations between Incident Niacin Therapy and Kidney Outcomes
10:00 AM - 12:00 PM
Examining the Associations between Incident Niacin Therapy and Kidney Outcomes
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Association of Prescribed Bicarbonate Therapy with Incident Kidney Failure in Veterans with CKD
10:00 AM - 12:00 PM
Association of Prescribed Bicarbonate Therapy with Incident Kidney Failure in Veterans with CKD
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Effect of Sodium Bicarbonate on Blood N-terminal Pro B-type Natriuretic Peptide (NT-proBNP) and Fetuin Levels: A Secondary Analysis of the VA-Bicarb Trial
10:00 AM - 12:00 PM
Effect of Sodium Bicarbonate on Blood N-terminal Pro B-type Natriuretic Peptide (NT-proBNP) and Fetuin Levels: A Secondary Analysis of the VA-Bicarb Trial
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Proteinuria Outcomes of Tenofovir Alafenamide Fumarate (TAF) vs. Tenofovir Disoproxil Fumarate (TDF) Regimens for Treatment of HIV, HBV, and HIV PrEP: A Systematic Literature Review and Meta-Analysis
10:00 AM - 12:00 PM
Proteinuria Outcomes of Tenofovir Alafenamide Fumarate (TAF) vs. Tenofovir Disoproxil Fumarate (TDF) Regimens for Treatment of HIV, HBV, and HIV PrEP: A Systematic Literature Review and Meta-Analysis
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Association between Urate-Lowering Therapy and Kidney Failure in Patients with CKD
10:00 AM - 12:00 PM
Association between Urate-Lowering Therapy and Kidney Failure in Patients with CKD
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Efficacy and Safety of SEL-212 in Patients with Refractory Gout and CKD: A Post Hoc Analysis from the Two Phase 3 DISSOLVE Studies
10:00 AM - 12:00 PM
Efficacy and Safety of SEL-212 in Patients with Refractory Gout and CKD: A Post Hoc Analysis from the Two Phase 3 DISSOLVE Studies
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Effect of Different Erythropoiesis-Stimulating Agents on Mortality and Kidney Disease Progression among Nondialysis-Dependent Patients with CKD
10:00 AM - 12:00 PM
Effect of Different Erythropoiesis-Stimulating Agents on Mortality and Kidney Disease Progression among Nondialysis-Dependent Patients with CKD
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Health Effects (Renal) of Extra Strength Avmacol (HEROES) Study: Interim Update from the Phase 2 Randomized Double-Blind Placebo-Controlled Trial
10:00 AM - 12:00 PM
Health Effects (Renal) of Extra Strength Avmacol (HEROES) Study: Interim Update from the Phase 2 Randomized Double-Blind Placebo-Controlled Trial
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Hyperkalemia Treatment Strategies by Specialty in the TRACK Study: Interim Analysis
10:00 AM - 12:00 PM
Hyperkalemia Treatment Strategies by Specialty in the TRACK Study: Interim Analysis
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Weight-Based Sliding Scale vs. Fixed-Dose Loop Diuretics for Fluid Overload in CKD: A Retrospective Analysis
10:00 AM - 12:00 PM
Weight-Based Sliding Scale vs. Fixed-Dose Loop Diuretics for Fluid Overload in CKD: A Retrospective Analysis
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Effects of Pediococcus acidilactici GKA4 Supplementation on Proinflammatory Cytokines in Early-Stage CKD
10:00 AM - 12:00 PM
Effects of Pediococcus acidilactici GKA4 Supplementation on Proinflammatory Cytokines in Early-Stage CKD
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Prognostic Enrichment Using the Klinrisk Model: Insights from Landmark Kidney Disease Clinical Trials
10:00 AM - 12:00 PM
Prognostic Enrichment Using the Klinrisk Model: Insights from Landmark Kidney Disease Clinical Trials
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Composite Primary Outcome Variables in Nephrology Clinical Trials
10:00 AM - 12:00 PM
Composite Primary Outcome Variables in Nephrology Clinical Trials
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Examining the Association between Quality of Life and Functional Status in African American Adults with CKD in Southeast Wisconsin: A Cross-Sectional Study
10:00 AM - 12:00 PM
Examining the Association between Quality of Life and Functional Status in African American Adults with CKD in Southeast Wisconsin: A Cross-Sectional Study
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
